What is the optimal level of intervention for a child with autism? How can we predict the outcome of the intervention? How many hours a week should we be spending on treatment? While these questions are often easily answered for predictable conditions like diabetes, they are much harder to pinpoint for behavioral health disabilities.

Co-founder and CEO of RethinkFirst, Daniel Etra, has identified a stark lack of data on treatment outcomes for behavioral health patients. To bridge this gap, Rethink delivers intervention at scale for developmental disabilities and neurodiverse conditions.

In this episode, Daniel discusses Rethink’s journey to becoming an industry-leading behavioral health technology company. With decades of experience as a successful entrepreneur, Daniel shares his insights on building a successful company at scale in today’s climate.

Do you have any thoughts? Please email us at hello@rosenmaninstitute.org. We post new episodes every Monday. “The Health Technology Podcast” is produced by Herminio Neto, hosted by Christine Winoto, and engineered by Andrew John Rojek